Detalhe da pesquisa
1.
mRNA therapy corrects defective glutathione metabolism and restores ureagenesis in preclinical argininosuccinic aciduria.
Sci Transl Med
; 16(729): eadh1334, 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38198573
2.
Imaging the master regulator of the antioxidant response in non-small cell lung cancer with positron emission tomography.
bioRxiv
; 2023 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38168428
3.
Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics.
Theranostics
; 9(8): 2129-2142, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31149033
4.
Radiosensitivity of Prostate Cancer Cell Lines for Irradiation from Beta Particle-emitting Radionuclide ¹77Lu Compared to Alpha Particles and Gamma Rays.
Anticancer Res
; 36(1): 103-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26722033
5.
Radioimmunotherapy for Prostate Cancer--Current Status and Future Possibilities.
Semin Nucl Med
; 46(2): 165-79, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26897720
6.
Intratherapeutic biokinetic measurements, dosimetry parameter estimates, and monitoring of treatment efficacy using cerenkov luminescence imaging in preclinical radionuclide therapy.
J Nucl Med
; 56(3): 444-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25655628
7.
Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a (111)In-radiolabelled monoclonal antibody, 11B6.
EJNMMI Res
; 4(1): 51, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26116115